Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P850064/S058

LifePulse High Frequency Ventilator (LifePulse HFV) Model 204

Bunnell, Inc. · Decision date May 7, 2026

FDA DECISIONP850064/S058

What did the FDA decide?

FDA records P850064/S058 as a supplement to PMA P850064, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated May 7, 2026.

FDA approval order statement

This is a 30-DN to provide the change in power cord testing as a result of a CAPA investigation into a miswiring of one single power cord. the testing is adequate to test the incoming inspection for cross-wired power cords and not as a complete safety check.
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Anesthesiology
Decision date
May 7, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P850064/S058
Regulatory pathway
PMA supplement
Applicant
Bunnell, Inc.
Product code
LSZ
Decision code
OK30
Decision date
May 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: VENTILATOR, HIGH FREQUENCY.

Applicant
Bunnell, Inc.
Product code
LSZ
FDA device class
3

For the original device and its historical approval scope, see PMA P850064. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P850064 · Original PMA

    MODEL 203 LIFE PULSE HIGH FREQUENCY VENTILATOR

  2. P850064/S055 · Related supplement

    LifePulse High Frequency Ventilator (HFV)

  3. P850064/S058 received

    Application receipt date recorded by FDA.

  4. P850064/S058 · FDA decision

    30-Day Notice

  5. P850064/S056 · Related supplement

    LifePulse High Frequency Ventilator

Timeline entries are records held by MedtechLedger for P850064. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P850064

Product / regulatory recordCompanyPathwayDecision dateSource
Bunnell, Inc.PMA approvalJun 30, 1988FDA
Bunnell, Inc.PMA supplementJul 25, 2025FDA
Bunnell, Inc.PMA supplementSep 28, 2026FDA

Explore the linked device profile

Other records with product code LSZ

Product / regulatory recordCompanyPathwayDecision dateSource
ZOLL MEDICAL CORPORATIONPMA supplementJul 23, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bunnell, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
436 Lawndale Dr., Salt Lake City, UT, 84115

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records